The Malaysian Medical Association (MMA) has urged the Health Ministry and Malaysian Medical Council (MMC) to curb alleged corporate interference in clinical decisions, claiming that it exposes patients to increased safety risks.

The group alleged that corporate entities, including healthcare insurers and third-party administrators (TPA), have been increasingly issuing directives prioritising commercial interests over patient safety, and called upon the government to urgently address the regulatory loopholes surrounding corporate healthcare.